[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-345273-en":59,"doc-seo-345273-105":99},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":72,"language":73,"language_code":74,"site_id":75,"html_lang":74,"table_of_contents":76,"faqs":77,"seo_title":78,"seo_description":66,"update_tm":79,"read_time":80,"preview_page_count":19,"preview_urls":81},345273,8796095461564,"Liam","https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Identification and validation of hub genes involved in papillary thyroid carcinoma progression","Papillary Thyroid Cancer (PTC) is a common endocrine malignancy whose incidence has risen markedly over recent decades. This study uses PTC transcriptome sequencing to identify gene alterations and hub biomarkers linked to disease progression. Differential expression analysis finds 1550 overlapping DEGs versus normal thyroid tissues and 3192 DEGs versus normal adjacent tissues. KEGG and PPI analyses prioritize FN1, SDC1, and MAPK1, and RT-qPCR and western blot validate their upregulation, supporting diagnostic and therapeutic potential.","Khalid et al. BMC Cancer (2026) 26:536 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15841-6](https://doi.org/10.1186/s12885-026-15841-6)  \nRESEARCH Open Access  \nIdentification and validation of hub genes involved in papillary thyroid carcinoma progression  \nZunera Khalid1,3, Khalid Khan2, Farah Nazir3, Chengbing Yao4, Seyed Majid Mousavi Mehmandousti3, Yuhua Shang4, Humaira Amin5, Yixiang Xing1, Xikong Pan6, Shoubing Zhou7,8, Qingyu Cheng9, Tengchuan Jin2,3,4,9,10,11* and Xucai Zheng6*  \nAbstract  \nPapillary Thyroid Cancer (PTC) is one of the most prevalent endocrine malignancies, and its incidence rate has almost tripled over the past three decades. The current study aimed to identify gene alterations and biomarkers contributing to PTC progression. Based on PTC transcriptome sequencing data, differential gene expression analysis is used to systematically categorize hub genes associated with PTC progression. A total of 1550 overlapping differentially expressed genes (DEGs) were identified in PTC compared to normal thyroid tissues, including 1149 upregulated and 401 downregulated genes. In addition, 3192 DEGs were detected in PTC relative to their normal adjacent tissues (NATs), comprising 1431 upregulated and 1761 downregulated genes. KEGG pathway analysis revealed pathways associated with cancer, proteoglycans in cancer, parathyroid hormone synthesis, and chemical carcinogenesis receptor activity. Protein-protein interaction (PPI) network analysis identified FN1, SDC1, and MAPK1 as highly ranked hub genes among the upregulated genes involved in several cancer pathways, including the PID Syndecan-1 pathway, Proteoglycans in cancer, and the CCL18 signaling pathway. The gene expression validation through Reverse Transcription-quantitative Polymerase Chain Reaction (RT-qPCR) further validated the significance of the above findings, demonstrating substantial upregulation of FN1 (7 .4-fold increase), SDC1 (5 . 2-fold increase), and MAPK1 (5 . 8-fold increase) in papillary thyroid tissues relative to their adjacent normal tissues. Western blot analysis further validated the upregulation of FN1 at the protein level. These findings highlight a strong association between the identified hub genes (FN1, SDC1, and MAPK1) and papillary thyroid cancer, supporting their potential as diagnostic biomarkers and therapeutic targets. Further validation through in vivo experiments and functional assays will be essential to confirm their roles in PTC pathogenesis and to elucidate their clinical implications. Keywords Papillary Thyroid Cancer, Differential Gene expression, Upregulated genes, Hub genes, RT-qPCR, Drug targets  \n*Correspondence: Tengchuan Jin [jint@ustc.edu.cn](jint@ustc.edu.cn)  \nXucai Zheng [zhengxucai@ustc.edu.cn](zhengxucai@ustc.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4","cbCaimx6pKHscQvW","https://ap.wps.com/l/cbCaimx6pKHscQvW","pdf",4584862,18,"English","en",105,"# Abstract\n## Graphical abstract\n## Introduction\n### Thyroid cancer epidemiology and PTC burden\n### Molecular pathways and genetic drivers in PTC\n### Transcriptome/NGS data and the need for reliable analyses","[{\"question\":\"What is the main goal of this study on papillary thyroid carcinoma (PTC)?\",\"answer\":\"To identify gene alterations and hub biomarkers that contribute to PTC progression using transcriptome-based differential expression analyses and validation experiments.\"},{\"question\":\"Which hub genes were prioritized and validated as associated with PTC progression?\",\"answer\":\"FN1, SDC1, and MAPK1 were ranked as highly connected hub genes, and their upregulation was validated using RT-qPCR and western blot.\"},{\"question\":\"How were the gene expression findings validated in this research?\",\"answer\":\"The study confirmed key results with reverse transcription-quantitative PCR (RT-qPCR) for gene-level upregulation and used western blot to validate FN1 at the protein level.\"}]","Identification and validation of hub genes involved in papillary thyroid carcinoma progression | PDF",1790057081,45,[82,86,90,95],{"page_no":8,"url":83,"width":84,"height":85},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b3e102730522fbeb47d3aafb6567fbea.webp",983,1310,{"page_no":14,"url":87,"width":88,"height":89},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e546acfe4e08409592551aad5f8c4ae2.webp",982,1309,{"page_no":91,"url":92,"width":93,"height":94},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a284d36b7b4c740a76ef89722dab591.webp",981,1308,{"page_no":19,"url":96,"width":97,"height":98},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a378209c95f1929f155577d33a27c38.webp",980,1306,{"code":4,"msg":100,"data":101},"ok",{"site_id":75,"language":74,"slug":102,"title":65,"keywords":103,"description":66,"schema_data":104,"social_meta":157,"head_meta":159,"extra_data":161,"updated_unix":162},"identification-and-validation-of-hub-genes-involved-in-papillary-thyroid-carcinoma-progression","",{"@graph":105,"@context":156},[106,119,139],{"@type":107,"itemListElement":108},"BreadcrumbList",[109,113,115,117],{"item":110,"name":111,"@type":112,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":114,"name":9,"@type":112,"position":14},"https://docshare.wps.com/document/",{"item":116,"name":40,"@type":112,"position":91},"https://docshare.wps.com/document/research-report/",{"item":118,"name":65,"@type":112,"position":19},"https://docshare.wps.com/document/identification-and-validation-of-hub-genes-involved-in-papillary-thyroid-carcinoma-progression/345273/",{"url":118,"name":65,"@type":120,"image":121,"author":126,"headline":65,"publisher":128,"fileFormat":131,"inLanguage":74,"description":66,"dateModified":132,"datePublished":133,"encodingFormat":131,"isAccessibleForFree":134,"interactionStatistic":135},"DigitalDocument",{"url":122,"@type":123,"width":124,"height":125},"https://docshare.wps.com/thumbnails/identification-and-validation-of-hub-genes-involved-in-papillary-thyroid-carcinoma-progression/345273.png","ImageObject",300,407,{"name":63,"@type":127},"Person",{"url":110,"name":129,"@type":130},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":136,"interactionType":137,"userInteractionCount":44},"InteractionCounter",{"@type":138},"ViewAction",{"@type":140,"mainEntity":141},"FAQPage",[142,148,152],{"name":143,"@type":144,"acceptedAnswer":145},"What is the main goal of this study on papillary thyroid carcinoma (PTC)?","Question",{"text":146,"@type":147},"To identify gene alterations and hub biomarkers that contribute to PTC progression using transcriptome-based differential expression analyses and validation experiments.","Answer",{"name":149,"@type":144,"acceptedAnswer":150},"Which hub genes were prioritized and validated as associated with PTC progression?",{"text":151,"@type":147},"FN1, SDC1, and MAPK1 were ranked as highly connected hub genes, and their upregulation was validated using RT-qPCR and western blot.",{"name":153,"@type":144,"acceptedAnswer":154},"How were the gene expression findings validated in this research?",{"text":155,"@type":147},"The study confirmed key results with reverse transcription-quantitative PCR (RT-qPCR) for gene-level upregulation and used western blot to validate FN1 at the protein level.","https://schema.org",{"og:url":118,"og:type":158,"og:title":65,"og:site_name":129,"og:description":66},"article",{"robots":160,"canonical":118},"index,follow",{"doc_id":61,"site_id":75},1790125124]